Multidrug-Resistant<i>Acinetobacter baumannii</i>

Manikal, 2000, Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage., Clin Infect Dis, 31, 101, 10.1086/313902

El Shafie, 2004, Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit., J Hosp Infect, 56, 101, 10.1016/j.jhin.2003.09.024

Corbella, 2000, Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii., J Clin Microbiol, 38, 4086, 10.1128/JCM.38.11.4086-4095.2000

Gales, 2001, Emerging importance of multidrug-resistant Acinetobacter species and Stentrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features and trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)., Clin Infect Dis, 32, 104, 10.1086/320183

Go ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano N, Clinical and molecular epidemiology ofAcinetobacterinfections sensitive only to polymyxin B and sulbactam. Lancet North Am Ed. 1994;344:1329–32.

Acar, 1997, Consequences of bacterial resistance to antibiotics in medical practice., Clin Infect Dis, 24, S17, 10.1093/clinids/24.Supplement_1.S17

Ayan, 2003, Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital., J Hosp Infect, 54, 39, 10.1016/S0195-6701(03)00076-8

Bergogne, 1996, Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features., Clin Microbiol Rev, 9, 148, 10.1128/CMR.9.2.148

Landman, 2002, Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY., Arch Intern Med, 162, 1515, 10.1001/archinte.162.13.1515

Aygun, 2002, Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit., J Hosp Infect, 52, 259, 10.1053/jhin.2002.1300

Quinn, 1998, Clinical problems posed by multiresistant nonfermenting gram-negative pathogens., Clin Infect Dis, 27, S117, 10.1086/514912

Bergogne-Berezin, 1996, Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features., Clin Microbiol Rev, 9, 148, 10.1128/CMR.9.2.148

Getchell-White, 1989, The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus., Infect Control Hosp Epidemiol, 10, 402, 10.1086/646061

Wendt, 1997, Survival of Acinetobacter baumannii on dry surfaces., J Clin Microbiol, 35, 1394, 10.1128/JCM.35.6.1394-1397.1997

Villegas, 2003, Acinetobacter outbreaks1977–2000., Infect Control Hosp Epidemiol, 24, 284, 10.1086/502205

Hsueh, 2002, Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan., Emerg Infect Dis, 8, 827, 10.3201/eid0801.000454

Villers, 1998, Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology., Ann Intern Med, 129, 182, 10.7326/0003-4819-129-3-199808010-00003

Biendo, 1999, Epidemiological study of an Acinetobacter baumannii outbreak by using a combination of antibiotyping and ribotyping., J Clin Microbiol, 37, 2170, 10.1128/JCM.37.7.2170-2175.1999

Murray, 1979, Aminoglycoside-modifying enzymes among clinical isolates of Acinetobacter calcoaceticus subsp. anitratus: explanation for high-level aminoglycoside resistance., Antimicrob Agents Chemother, 15, 190, 10.1128/AAC.15.2.190

Zeana, 2003, The epidemiology of multidrug-resistant Acinetobacter baumannii: does the community represent a reservoir?, Infect Control Hosp Epidemiol, 24, 275, 10.1086/502209

Melamed, 2003, Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit., J Hosp Infect, 53, 31, 10.1053/jhin.2002.1324

Simhon, 2001, Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel., J Clin Microbiol, 39, 389, 10.1128/JCM.39.1.389-391.2001

Bonten, 1998, The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable., Arch Intern Med, 158, 1127, 10.1001/archinte.158.10.1127

Carmeli, 2002, Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus., Emerg Infect Dis, 8, 802, 10.3201/eid0808.010418

McCabe, 1962, Gram-negative bacteremia I. Etiology and ecology., Arch Intern Med, 110, 847, 10.1001/archinte.1962.03620240029006

Gouby, 1992, Use of pulsed-field gel electrophoresis for investigation of hospital outbreaks of Acinetobacter baumannii., J Clin Microbiol, 30, 1588, 10.1128/JCM.30.6.1588-1591.1992

Tenover, 1995, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing., J Clin Microbiol, 33, 2233, 10.1128/JCM.33.9.2233-2239.1995

Garner, 1988, CDC definitions for nosocomial infections, 1988., Am J Infect Control, 16, 128, 10.1016/0196-6553(88)90053-3

Colodner, 2004, Risk factors for development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients., Eur J Clin Microbiol Infect Dis, 23, 163, 10.1007/s10096-003-1084-2

Ben-Ami R, Navon-Venezia S, Leavitt A, Schwaber M, Schwartz D, Carmeli Y. Intestinal carriage ofEnterobacteriaceaewith extended spectrum beta-lactamase (ESBL)-producing phenotype on admission to a medical service [abstract]. Presented at the 43rd annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 2003 Sep, Chicago, IL. Washington: American Society for Microbiology.

Ben-Ami R, Schwartz D, Navon-Venezia S, Leavitt A, Schwaber M, Carmeli Y. Risk factors for intestinal carriage ofPseudomonas aeruginosaon admission to a medical service [abstract]. Presented at the 43rd annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 2003 Sep, Chicago, IL. Washington: American Society for Microbiology.

Nanni, 2000, Increased incidence of infection in verapamil-treated kidney transplant recipients., Transplant Proc, 32, 551, 10.1016/S0041-1345(00)00886-1

Tisa, 2000, Effects of organic antagonists of Ca, Na, and K on chemotaxis and motility of Escherichia coli., J Bacteriol, 182, 4856, 10.1128/JB.182.17.4856-4861.2000